Esta tradução está a ser preparada. Entretanto, mostramos temporariamente a versão original em inglês.
Negócios · 06/03/19971 min de leitura
Implantation or Injectable Dosage Form New Animal Drugs; Sarafloxacin Hydrochloride
Tradução automática local · Idioma original da fonte
Resumo
The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Abbott Laboratories. The supplement provides for use of sarafloxacin hydrochloride solution for injection in 18-day embryonated broiler eggs for control of early chick mortality associated with Escherichia coli organisms susceptible to sarafloxacin.
Idioma original da fonte: Federal Register — Food and Drug AdministrationAbrir o comunicado original →